⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
C3a–C3AR1 Pathway Inhibitors
Current understanding
To be populated as evidence accumulates.
Evidence log
Open questions
Related
Contributing findings
Canonical complement C3a-C3AR1 signalling in ageing and age-related disease: Cellular mechanisms, tissue-specific effects and translational challenges.
09-sep-2026
novelty 3
per-area 2
mentions